Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow-to-Debt Ratio
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow-to-Debt Ratio of 0.43x as of December 2025, meaning its operating cash flow of CN¥345.31 Million could theoretically repay 0% of its total liabilities (CN¥797.40 Million) in one year. See free cash flow generation of Jiangsu Hualv Biological Technology Co.L to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. Also explore 300970 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year debt coverage analysis for Jiangsu Hualv Biological Technology Co.Ltd.. For market capitalisation and broader financial context, see how much is Jiangsu Hualv Biological Technology Co.L worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | CN¥345.31 Million | CN¥797.40 Million | ▲ +147.0% |
| 2024 | 0.18x | CN¥137.80 Million | CN¥786.12 Million | ▼ -42.0% |
| 2023 | 0.30x | CN¥166.67 Million | CN¥551.03 Million | ▼ -23.0% |
| 2022 | 0.39x | CN¥179.84 Million | CN¥457.83 Million | ▲ +107.5% |
| 2021 | 0.19x | CN¥83.08 Million | CN¥438.92 Million | ▼ -70.2% |
| 2020 | 0.63x | CN¥199.09 Million | CN¥313.67 Million | ▼ -16.8% |
| 2019 | 0.76x | CN¥213.96 Million | CN¥280.52 Million | — |